# Aurinia Pharmaceuticals Inc.: Form SC 13D/A, filed Mar 20, 2024

- Company: [Aurinia Pharmaceuticals Inc.](/companies/auph.md) (CIK 1600620)
- Form: SC 13D/A
- Filed: 2024-03-20
- Accepted by EDGAR: Mar 20, 2024, 17:23 ET
- Period: not reported
- Accession: 0001104659-24-036780
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1600620/000110465924036780/tm249351d1_sc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1600620/000110465924036780/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1600620/000110465924036780/tm249351d1_sc13da.htm

Filed Mar 20, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-036780. Last ingested by Listed: Oct 30, 2026, 08:08 ET. No prices; not investment advice.